Of note, in the control group high frequency of MSLN+ tumor cells was detected at the intermediate time point and lower at the humane endpoint, while the frequency of MSLN+ tumor cells in MSLN-CAR-treated mice was low at both the intermediate and humane endpoint (figure 2E). The gene discussed is MSLN; the disease is neoplasm.